Compare Stocks

2 / 10
Try these comparisons:

Stock Comparison

ALMS vs VTRS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
ALMS
Alumis Inc. Common Stock

Biotechnology

HealthcareNASDAQ • US
Market Cap$2.79B
5Y Perf.+78.6%
VTRS
Viatris Inc.

Drug Manufacturers - Specialty & Generic

HealthcareNASDAQ • US
Market Cap$20.25B
5Y Perf.+63.6%

ALMS vs VTRS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
ALMS logoALMS
VTRS logoVTRS
IndustryBiotechnologyDrug Manufacturers - Specialty & Generic
Market Cap$2.79B$20.25B
Revenue (TTM)$22M$14.56B
Net Income (TTM)$-245M$-296M
Gross Margin96.3%34.4%
Operating Margin-20.6%1.0%
Forward P/E7.1x
Total Debt$37M$14.70B
Cash & Equiv.$90M$1.35B

ALMS vs VTRSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

ALMS
VTRS
StockJun 24May 26Return
Alumis Inc. Common … (ALMS)100178.6+78.6%
Viatris Inc. (VTRS)100163.6+63.6%

Price return only. Dividends and distributions are not included.

Quick Verdict: ALMS vs VTRS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: VTRS leads in 4 of 6 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Alumis Inc. Common Stock is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. As sector peers, any of these can serve as alternatives in the same allocation.
ALMS
Alumis Inc. Common Stock
The Growth Play

ALMS is the clearest fit if your priority is growth exposure and long-term compounding.

  • EPS growth 72.4%
  • 78.6% 10Y total return vs VTRS's -51.5%
  • Lower volatility, beta 1.77, Low D/E 12.3%, current ratio 4.34x
Best for: growth exposure and long-term compounding
VTRS
Viatris Inc.
The Income Pick

VTRS carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 0 yrs, beta 0.99, yield 2.8%
  • Beta 0.99, yield 2.8%, current ratio 1.30x
  • -2.0% margin vs ALMS's -11.1%
Best for: income & stability and defensive
See the full category breakdown
CategoryWinnerWhy
GrowthALMS logoALMS-2.5% revenue growth vs VTRS's -3.0%
Quality / MarginsVTRS logoVTRS-2.0% margin vs ALMS's -11.1%
Stability / SafetyVTRS logoVTRSBeta 0.99 vs ALMS's 1.77
DividendsVTRS logoVTRS2.8% yield; the other pay no meaningful dividend
Momentum (1Y)ALMS logoALMS+396.0% vs VTRS's +107.8%
Efficiency (ROA)VTRS logoVTRS-0.8% ROA vs ALMS's -57.6%, ROIC -6.6% vs -184.1%

ALMS vs VTRS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

ALMSAlumis Inc. Common Stock
FY 2025
License
72.3%$17M
Collaboration Revenue
27.7%$7M
VTRSViatris Inc.
FY 2025
Brands
64.4%$9.2B
Generics
35.6%$5.1B

ALMS vs VTRS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLVTRSLAGGINGALMS

Income & Cash Flow (Last 12 Months)

VTRS leads this category, winning 4 of 5 comparable metrics.

VTRS is the larger business by revenue, generating $14.6B annually — 658.3x ALMS's $22M. VTRS is the more profitable business, keeping -2.0% of every revenue dollar as net income compared to ALMS's -11.1%.

MetricALMS logoALMSAlumis Inc. Commo…VTRS logoVTRSViatris Inc.
RevenueTrailing 12 months$22M$14.6B
EBITDAEarnings before interest/tax-$453M$2.3B
Net IncomeAfter-tax profit-$245M-$296M
Free Cash FlowCash after capex-$373M$1.7B
Gross MarginGross profit ÷ Revenue+96.3%+34.4%
Operating MarginEBIT ÷ Revenue-20.6%+1.0%
Net MarginNet income ÷ Revenue-11.1%-2.0%
FCF MarginFCF ÷ Revenue-16.9%+11.7%
Rev. Growth (YoY)Latest quarter vs prior year+8.1%
EPS Growth (YoY)Latest quarter vs prior year+38.7%+105.9%
VTRS leads this category, winning 4 of 5 comparable metrics.

Valuation Metrics

VTRS leads this category, winning 2 of 3 comparable metrics.
MetricALMS logoALMSAlumis Inc. Commo…VTRS logoVTRSViatris Inc.
Market CapShares × price$2.8B$20.2B
Enterprise ValueMkt cap + debt − cash$2.7B$33.6B
Trailing P/EPrice ÷ TTM EPS-8.31x-5.80x
Forward P/EPrice ÷ next-FY EPS est.7.12x
PEG RatioP/E ÷ EPS growth rate
EV / EBITDAEnterprise value multiple248.54x
Price / SalesMarket cap ÷ Revenue116.09x1.42x
Price / BookPrice ÷ Book value/share67.05x1.38x
Price / FCFMarket cap ÷ FCF10.45x
VTRS leads this category, winning 2 of 3 comparable metrics.

Profitability & Efficiency

VTRS leads this category, winning 5 of 8 comparable metrics.

VTRS delivers a -2.0% return on equity — every $100 of shareholder capital generates $-2 in annual profit, vs $-76 for ALMS. ALMS carries lower financial leverage with a 0.12x debt-to-equity ratio, signaling a more conservative balance sheet compared to VTRS's 1.00x. On the Piotroski fundamental quality scale (0–9), VTRS scores 4/9 vs ALMS's 3/9, reflecting mixed financial health.

MetricALMS logoALMSAlumis Inc. Commo…VTRS logoVTRSViatris Inc.
ROE (TTM)Return on equity-75.5%-2.0%
ROA (TTM)Return on assets-57.6%-0.8%
ROICReturn on invested capital-184.1%-6.6%
ROCEReturn on capital employed-144.4%-8.1%
Piotroski ScoreFundamental quality 0–934
Debt / EquityFinancial leverage0.12x1.00x
Net DebtTotal debt minus cash-$53M$13.4B
Cash & Equiv.Liquid assets$90M$1.3B
Total DebtShort + long-term debt$37M$14.7B
Interest CoverageEBIT ÷ Interest expense-0.51x
VTRS leads this category, winning 5 of 8 comparable metrics.

Total Returns (Dividends Reinvested)

ALMS leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in ALMS five years ago would be worth $17,865 today (with dividends reinvested), compared to $14,034 for VTRS. Over the past 12 months, ALMS leads with a +396.0% total return vs VTRS's +107.8%. The 3-year compound annual growth rate (CAGR) favors VTRS at 24.2% vs ALMS's 21.3% — a key indicator of consistent wealth creation.

MetricALMS logoALMSAlumis Inc. Commo…VTRS logoVTRSViatris Inc.
YTD ReturnYear-to-date+165.3%+40.5%
1-Year ReturnPast 12 months+396.0%+107.8%
3-Year ReturnCumulative with dividends+78.6%+91.8%
5-Year ReturnCumulative with dividends+78.6%+40.3%
10-Year ReturnCumulative with dividends+78.6%-51.5%
CAGR (3Y)Annualised 3-year return+21.3%+24.2%
ALMS leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

VTRS leads this category, winning 2 of 2 comparable metrics.

VTRS is the less volatile stock with a 0.99 beta — it tends to amplify market swings less than ALMS's 1.77 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTRS currently trades 99.7% from its 52-week high vs ALMS's 77.6% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricALMS logoALMSAlumis Inc. Commo…VTRS logoVTRSViatris Inc.
Beta (5Y)Sensitivity to S&P 5001.77x0.99x
52-Week HighHighest price in past year$30.60$17.45
52-Week LowLowest price in past year$2.76$8.19
% of 52W HighCurrent price vs 52-week peak+77.6%+99.7%
RSI (14)Momentum oscillator 0–10054.375.7
Avg Volume (50D)Average daily shares traded1.4M10.6M
VTRS leads this category, winning 2 of 2 comparable metrics.

Analyst Outlook

Insufficient data to determine a leader in this category.

Wall Street rates ALMS as "Buy" and VTRS as "Hold". Consensus price targets imply 61.8% upside for ALMS (target: $38) vs -12.3% for VTRS (target: $15). VTRS is the only dividend payer here at 2.76% yield — a key consideration for income-focused portfolios.

MetricALMS logoALMSAlumis Inc. Commo…VTRS logoVTRSViatris Inc.
Analyst RatingConsensus buy/hold/sellBuyHold
Price TargetConsensus 12-month target$38.44$15.25
# AnalystsCovering analysts812
Dividend YieldAnnual dividend ÷ price+2.8%
Dividend StreakConsecutive years of raises0
Dividend / ShareAnnual DPS$0.48
Buyback YieldShare repurchases ÷ mkt cap0.0%+2.5%
Insufficient data to determine a leader in this category.
Key Takeaway

VTRS leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). ALMS leads in 1 (Total Returns).

Best OverallViatris Inc. (VTRS)Leads 4 of 6 categories
Loading custom metrics...

ALMS vs VTRS: Frequently Asked Questions

9 questions · data-driven answers · updated daily

01

Is ALMS or VTRS a better buy right now?

Analysts rate Alumis Inc.

Common Stock (ALMS) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which is the better long-term investment — ALMS or VTRS?

Over the past 5 years, Alumis Inc.

Common Stock (ALMS) delivered a total return of +78. 6%, compared to +40. 3% for Viatris Inc. (VTRS). Over 10 years, the gap is even starker: ALMS returned +78. 6% versus VTRS's -51. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

03

Which is safer — ALMS or VTRS?

By beta (market sensitivity over 5 years), Viatris Inc.

(VTRS) is the lower-risk stock at 0. 99β versus Alumis Inc. Common Stock's 1. 77β — meaning ALMS is approximately 78% more volatile than VTRS relative to the S&P 500. On balance sheet safety, Alumis Inc. Common Stock (ALMS) carries a lower debt/equity ratio of 12% versus 100% for Viatris Inc. — giving it more financial flexibility in a downturn.

04

Which is growing faster — ALMS or VTRS?

On earnings-per-share growth, the picture is similar: Alumis Inc.

Common Stock grew EPS 72. 4% year-over-year, compared to -466. 0% for Viatris Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

05

Which has better profit margins — ALMS or VTRS?

Viatris Inc.

(VTRS) is the more profitable company, earning -24. 6% net margin versus -1011. 7% for Alumis Inc. Common Stock — meaning it keeps -24. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: VTRS leads at -18. 6% versus -1886. 9% for ALMS. At the gross margin level — before operating expenses — ALMS leads at 96. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

06

Is ALMS or VTRS more undervalued right now?

Analyst consensus price targets imply the most upside for ALMS: 61.

8% to $38. 44.

07

Which pays a better dividend — ALMS or VTRS?

In this comparison, VTRS (2.

8% yield) pays a dividend. ALMS does not pay a meaningful dividend and should not be held primarily for income.

08

Is ALMS or VTRS better for a retirement portfolio?

For long-horizon retirement investors, Viatris Inc.

(VTRS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 99), 2. 8% yield). Alumis Inc. Common Stock (ALMS) carries a higher beta of 1. 77 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VTRS: -51. 5%, ALMS: +78. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

09

What are the main differences between ALMS and VTRS?

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

VTRS pays a dividend while ALMS does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.

Stocks Like

ALMS

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
  • Gross Margin > 57%
Run This Screen
Stocks Like

VTRS

Income & Dividend Stock

  • Sector: Healthcare
  • Market Cap > $100B
  • Revenue Growth > 5%
  • Gross Margin > 20%
Run This Screen

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.